The diagnostic application of serum growth hormone, insulin-like growth factor (IGF), and IGF binding protein measurements.
Selected combinations of tests for growth hormone and the growth mediating peptides, insulin-like growth factors, and their binding proteins have improved the diagnostic reliability of the procedures used in the investigation of growth abnormalities (GH deficiency, GH and IGF receptor deficiencies, GH excess, diabetes, or undernutrition) and in malignancies associated with hypoglycemia.
Teale
J D
JD
Dept. of Clinical Biochemistry, Immunology and Nutrition, St. Luke's Hospital, Guildford, Surrey, UK.
D000008:Abdominal Neoplasms / Q000097:blood / Q000150:complications / Q000175:diagnosis; D001827:Body Height; D002648:Child; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000097:blood / Q000175:diagnosis; D006130:Growth Disorders / Q000097:blood / Q000175:diagnosis* / Q000209:etiology; D013006:Growth Hormone / Q000097:blood*; D006801:Humans; D007003:Hypoglycemia / Q000097:blood / Q000150:complications / Q000175:diagnosis; D018969:Insulin-Like Growth Factor Binding Proteins / Q000097:blood*; D011502:Protein-Energy Malnutrition / Q000097:blood / Q000150:complications / Q000175:diagnosis; D013002:Somatomedins / Q000378:metabolism*